市場調査レポート

商品コード

1588502

ワクチンの市場規模、シェア、成長分析、技術別、タイプ別、適応疾患別、投与経路別、エンドユーザー別、地域別 - 産業予測、2024年～2031年

Vaccines Market Size, Share, Growth Analysis, By Technology, By Type, By Disease Indication, By Route of Administration, By End User, By Region - Industry Forecast 2024-2031

出版日: 2024年11月06日
発行: SkyQuest
ページ情報: 英文 212 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 778,146円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 910,284円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,042,422円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.82円

全表示
概要
目次

概要

サンプル依頼リストに入れる

世界のワクチンの市場規模は、2022年に720億米ドルとなり、2023年の746億6,000万米ドルから、2031年までには998億5,000万米ドルに成長し、予測期間（2024年～2031年）のCAGRは3.70％で成長する見通しです。

世界のワクチン市場は、慢性疾患の蔓延とヘルスケアへの関心の高まりにより、大幅な成長が見込まれています。医療技術が進化し、革新的なワクチンの研究開発への投資が強化されるにつれて、市場プレイヤーは新たな機会に遭遇する可能性が高いです。予防ヘルスケアの動向は、新しい予防接種プログラムの導入やワクチン啓蒙活動に支えられ、ワクチンの普及を促進すると予想されます。さらに、ワクチン接種の推進とワクチン技術の進歩は、市場参入企業の今後数年間の成長見通しをさらに高めると思われます。しかし、ワクチンに関する誤った情報の蔓延、多額の市場開拓コスト、厳しい規制要件といった課題は、市場の進展を妨げる可能性があります。全体として、ワクチン市場は、世界の健康課題と意識の高まりに対応して拡大すると思われますが、利害関係者は、新たなビジネスチャンスを生かすために、これらの障害を乗り越える必要があります。

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2023年）
主要な市場企業が採用した戦略
市場における最近の活動
主要企業の市場シェア（2023年）

主要企業プロファイル

GSK Plc（UK）
Merck & Co., Inc.（US）
Pfizer Inc.（US）
Sanofi（France）
CSL（Australia）
Emergent（US）
Johnson & Johnson Services, Inc.（US）
AstraZeneca（UK-Sweden）
Serum Institute of India Pvt., Ltd.（India）
Bavarian Nordic（Denmark）
Mitsubishi Tanabe Pharma Corporation（Japan）
Daiichi Sankyo Company, Limited（Japan）
Panacea Biotec（India）
Biological E Limited（India）
Bharat Biotech（India）
Novavax（US）
Inovio Pharmaceuticals（US）
Sinovac（China）
Incepta Pharmaceuticals Ltd.（Bangladesh）
Valneva SE（France）
VBI Vaccine Inc.（US）
Bio Farma（Indonesia）
Microgen（Russia）
ZHI FEI Biological（China）
Indian Immunologicals Limited（India）

Product Code: SQMIG35H2262

Global Vaccines Market size was valued at USD 72 billion in 2022 and is poised to grow from USD 74.66 billion in 2023 to USD 99.85 billion by 2031, growing at a CAGR of 3.70% during the forecast period (2024-2031).

The global vaccines market is poised for substantial growth, driven by the increasing prevalence of chronic diseases and a heightened focus on healthcare. As medical technology evolves and investment in research and development of innovative vaccines intensifies, market players are likely to encounter new opportunities. The trend towards preventive healthcare is expected to foster greater vaccine adoption, supported by the introduction of new immunization programs and vaccine awareness initiatives. Furthermore, vaccination drives and advancements in vaccine technology will further enhance growth prospects for market participants over the forthcoming years. However, challenges such as widespread misinformation about vaccines, significant development costs, and strict regulatory requirements may hinder market progression. Overall, while the vaccines market is set to expand in response to global health challenges and growing awareness, stakeholders must navigate these obstacles to capitalize on the emerging opportunities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Vaccines market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Vaccines Market Segmental Analysis

Global Vaccines Market is segmented by Technology, Type, Disease Indication, Route of Administration, End User, and region. Based on Technology, the market is segmented into Conjugate Vaccines, Recombinant Vaccines, Inactivated & Subunit Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Viral Vector Vaccines, MRNA Vaccines, and Other Vaccines. Based on Type, the market is segmented into Multivalent Vaccines, and Monovalent Vaccines. Based on Disease Indication, the market is segmented into Pneumococcal Disease, Influenza, Combination Vaccines, HPV, Meningococcal Disease, Herpes Zoster, Rotavirus, MMR, Varicella, Hepatitis, DTP, Polio, RSV, and Other Disease Indications. Based on Route of Administration, the market is segmented into Oral Route (PO), Intranasal Route (NAS), Subcutaneous Route (Subcut), Intramuscular Route (IM). Based on End User, the market is segmented into Adult Vaccines, and Pediatric Vaccines. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Vaccines Market

The surge in the incidence of infectious and chronic diseases globally has significantly heightened awareness regarding the importance of preventive healthcare, acting as a key market driver for the global vaccines market. As populations become more cognizant of the benefits associated with vaccination, the demand for effective and reliable vaccine solutions is set to rise. Vaccines not only help in thwarting the spread of diseases but also play a crucial role in alleviating healthcare burdens before they escalate into major health crises. Consequently, this increasing awareness and proactive health management are expected to catalyze substantial growth in vaccine sales across diverse demographics.

Restraints in the Global Vaccines Market

The Global Vaccines market faces a significant restraint due to the intricacies involved in vaccine development, which includes extensive clinical trials and comprehensive testing protocols. These processes are not only time-consuming but also entail substantial financial investments, leading to high development costs for vaccine manufacturers. Such economic burdens can deter smaller companies from entering the market or limit innovation, ultimately constraining the overall growth potential of the vaccines market. Additionally, the lengthy timelines required for regulatory approval further exacerbate the challenge, making it difficult for new vaccines to be introduced swiftly to address emerging health threats.

Market Trends of the Global Vaccines Market

The global vaccines market is experiencing a notable trend towards personalized vaccines, driven by the increasing demand for personalized medicine and advancements in healthcare technology. Companies are increasingly focusing on developing tailored vaccines that cater to individual patient profiles, thereby enhancing efficacy and improving overall health outcomes. This shift not only opens new avenues for vaccine providers but also aligns with evolving patient expectations for customized healthcare solutions. As the landscape of immunization evolves, the integration of personalized vaccination strategies is anticipated to revolutionize the market, presenting significant growth opportunities and fortifying the commitment to improved public health initiatives.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Pricing Analysis
Technology Analysis
Value Chain Analysis
Patent Analysis
Supply Chain Analysis
PESTEL Analysis
Macro-Economic Indicators
Case Study Analysis
Customer & Buying Criteria Analysis

Vaccines Market by Technology

Market Overview
Conjugate Vaccines
Recombinant Vaccines
Inactivated & Subunit Vaccines
Live Attenuated Vaccines
Toxoid Vaccines
Viral Vector Vaccines
MRNA Vaccines
Other Vaccines

Vaccines Market by Type

Market Overview
Multivalent Vaccines
Monovalent Vaccines

Vaccines Market by Disease Indication

Market Overview
Pneumococcal Disease
Influenza
Combination Vaccines
HPV
Meningococcal Disease
Herpes Zoster
Rotavirus
MMR
Varicella
Hepatitis
DTP
Polio
RSV
Other Disease Indications

Vaccines Market by Route of Administration

Market Overview
Oral Route (PO)
Intranasal Route (NAS)
Subcutaneous Route (Subcut)
Intramuscular Route (IM)

Vaccines Market by End User

Market Overview
Adult Vaccines
Pediatric Vaccines

Vaccines Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

GSK Plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co., Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CSL (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Emergent (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson Services, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AstraZeneca (UK-Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Serum Institute of India Pvt., Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bavarian Nordic (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mitsubishi Tanabe Pharma Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Daiichi Sankyo Company, Limited (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Panacea Biotec (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biological E Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bharat Biotech (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novavax (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Inovio Pharmaceuticals (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sinovac (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Incepta Pharmaceuticals Ltd. (Bangladesh)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Valneva SE (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
VBI Vaccine Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio Farma (Indonesia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Microgen (Russia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ZHI FEI Biological (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Indian Immunologicals Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

ワクチンの市場規模、シェア、成長分析、技術別、タイプ別、適応疾患別、投与経路別、エンドユーザー別、地域別 - 産業予測、2024年～2031年

Vaccines Market Size, Share, Growth Analysis, By Technology, By Type, By Disease Indication, By Route of Administration, By End User, By Region - Industry Forecast 2024-2031

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主要な市場の考察

ワクチン市場：技術別

ワクチン市場：タイプ別

ワクチン市場：適応疾患別

ワクチン市場：投与経路別

ワクチン市場：エンドユーザー別

ワクチン市場：地域別